|
Referenz |
Lieferant |
Beschreibung |
Einheit |
Preis exkl. MwSt. |
|
|
|
USP-1A03390 |
USP |
N-Formyl Lenalidomide (N-(2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindoIin-4-yl)formamide) 25 mg |
|
2,864.00 CHF
3,007.20 €
|
|
|
|
USP-1A03400 |
USP |
Bortezomib L-phenylalanyl analog (COLD SHIPMENT REQUIRED) (((R)-3-methyl-1-((S)-3-phenyl-2-((S)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)propanamido)butyl)boronic acid) 25 mg |
|
2,604.00 CHF
2,734.20 €
|
|
|
|
USP-1A03410 |
USP |
Clarithromycin Furanyl Analog 25 mg |
|
1,372.00 CHF
1,440.60 €
|
|
|
|
USP-1A03420 |
USP |
Clarithromycin Z-Oxime 25 mg |
|
2,170.67 CHF
2,279.20 €
|
|
|
|
USP-1A03430 |
USP |
Anhydro Abiraterone (3-((8R,9S,10R,13S,14S)-10,13-dimethyl-2,7,8,9,10,11,12,13,14,15-decahydro-1H-cyclopenta[a]phenanthren-17-yl)pyridine, 17-(Pyridin-3-yl)androsta-3,5,16-triene) 25 mg |
|
4,166.67 CHF
4,375.00 €
|
|
|
|
USP-1A03440 |
USP |
Abiraterone Ethyl Ether (3-((3S,8R,9S,10R,13S,14S)-3-ethoxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pyridine) 25 mg |
|
1,736.00 CHF
1,822.80 €
|
|
|
|
USP-1A03450 |
USP |
Abiraterone Isopropyl Ether (3-((3S,8R,9S,10R,13S,14S)-3-isopropoxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pyridine, 3beta-Isopropoxy-17-(pyridin-3-yl)androsta-5,16-diene) 25 mg |
|
1,389.33 CHF
1,458.80 €
|
|
|
|
USP-1A03460 |
USP |
Desmethyl Bosentan (4-(tert-butyl)-N-(6-(2-hydroxyethoxy)-5-(2-hydroxyphenoxy)-[2,2'-bipyrimidin]-4-yl)benzenesulfonamide) 25 mg |
|
3,125.33 CHF
3,281.60 €
|
|
|
|
USP-1A03470 |
USP |
O-Acetyl Bosentan (2-((6-((4-(tert-butyl)phenyl)sulfonamido)-5-(2-methoxyphenoxy)-[2,2'-bipyrimidin]-4-yl)oxy)ethyl acetate) 25 mg |
|
2,430.67 CHF
2,552.20 €
|
|
|
|
USP-1A03480 |
USP |
Bosentan Bis4(tert-butylbenzenesulfonamide) (N,N'-(5-(2-methoxyphenoxy)-[2,2'-bipyrimidine]-4,6-diyl)bis(4-(tert-butyl)benzenesulfonamide)) 25 mg |
|
2,604.00 CHF
2,734.20 €
|
|
|
|
USP-1A03490 |
USP |
(1S,2R)-Eliglustat Diastereomer (N-[(1S,2R)-2-(2,3-Dihydro-1,4-benzodioxin-6-yl)-2-hydroxy-1-(1-pyrrolidinylmethyl)ethyl]octanamide) 25 mg |
|
4,686.67 CHF
4,921.00 €
|
|
|
|
USP-1A03500 |
USP |
Cyclopropyldiaminopurine (N6-cyclopropyl-9H-purine-2,6-diamine) 25 mg |
|
825.33 CHF
866.60 €
|
|
|
|
USP-1A03510 |
USP |
7-Keto abiraterone Acetate 25 mg |
|
2,604.00 CHF
2,734.20 €
|
|
|
|
USP-1A03520 |
USP |
3-Deoxy-3-acetyl Abiraterone-3-ene 25 mg |
|
1,736.00 CHF
1,822.80 €
|
|
|
|
USP-1A03530 |
USP |
3-Deoxy 3-Chloroabiraterone (3Beta-Chloro-17-(pyridin-3-yl)androsta-5,16-diene) 25 mg |
|
1,302.67 CHF
1,367.80 €
|
|
|
|
USP-1A03540 |
USP |
Fingolimod nonyl homolog (2-amino-2-(4-nonylphenethyl)propane-1,3-diol) 25 mg |
|
1,302.67 CHF
1,367.80 €
|
|
|
|
USP-1A03550 |
USP |
Fingolimod heptyl homolog (2-amino-2-(4-heptylphenethyl)propane-1,3-diol) 25 mg |
|
2,344.00 CHF
2,461.20 €
|
|
|
|
USP-1A03560 |
USP |
Fingolimod hexyl homolog (2-amino-2-(4-hexylphenethyl)propane-1,3-diol) 25 mg |
|
2,344.00 CHF
2,461.20 €
|
|
|
|
USP-1A03570 |
USP |
Fingolimod decyl homolog (2-amino-2-(4-decylphenethyl)propane-1,3-diol) 25 mg |
|
2,344.00 CHF
2,461.20 €
|
|
|
|
USP-1A03580 |
USP |
6-Keto Fulvestrant ((7Alpha,17Beta)-7-[9-[4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl]-3,17Beta-dihydroxyestra-1,3,5(10)-trien-6-one, 7Alpha-{9-[(4,4,5,5,5,-Pentafluoropentyl)sulfinyl]nonyl}estra-1,3,5(10)-triene-6-one-3,17Beta-diol) 25 mg |
|
2,430.67 CHF
2,552.20 €
|
|
|
|
USP-1A03590 |
USP |
5-Chloro Hydrochlorothiazide (5,6-dichloro-3,4-dihydro-2H-benzo[e][1,2,4]thiadiazine-7-sulfonamide 1,1-dioxide) 25 mg |
|
1,389.33 CHF
1,458.80 €
|
|
|
|
USP-1A03600 |
USP |
Mebetide (3-methyl-2H-benzo[e][1,2,4]thiadiazine 1,1-dioxide) 25 mg |
|
1,042.67 CHF
1,094.80 €
|
|
|
|
USP-1A03610 |
USP |
R,R-Lamivudine (4-amino-1-((2R,5R)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one 25 mg |
|
3,089.33 CHF
3,243.80 €
|
|
|
|
USP-1A03620 |
USP |
N-Methyl Lenalidomide (3-(4-(methylamino)-1-oxoisoindolin-2-yl)piperidine-2,6-dione) 25 mg |
|
2,084.00 CHF
2,188.20 €
|
|
|
|
USP-1A03630 |
USP |
Clarithromycin E-Oxime (COLD SHIPMENT REQUIRED) 25 mg |
|
1,129.33 CHF
1,185.80 €
|
|
|
|
USP-1A03640 |
USP |
Decladinosyl Clarithromycin (3-O-De(2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)-6-O-methylerythromycin, 3-O-Decladinosyl-6-O-methylerythromycin A) 25 mg |
|
954.67 CHF
1,002.40 €
|
|
|
|
USP-1A03650 |
USP |
Anhydroclarithromycin 25 mg |
|
1,216.00 CHF
1,276.80 €
|
|
|
|
USP-1A03660 |
USP |
N-Acetyl Lenalidomide (N-(2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)acetamide) 25 mg |
|
2,170.67 CHF
2,279.20 €
|
|
|
|
USP-1A03670 |
USP |
Fulvestrant sulfone ((7R,8R,9S,13S,14S,17S)-13-methyl-7-(9-((4,4,5,5,5-pentafluoropentyl)sulfonyl)nonyl)7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol) 25 mg |
|
1,996.00 CHF
2,095.80 €
|
|
|
|
USP-1A03680 |
USP |
Nonylene bisestradiol (8R,8'R,9S,9'S,13S,13'S,14S,14'S,17S,17'S)-7,7'-(nonane-1,9-diyl)bis(13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol) 25 mg |
|
4,340.00 CHF
4,557.00 €
|
|
|
|
USP-1A03730 |
USP |
Dabigatran Etexilate Acid (3-(2-(((4-(N-((hexyloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoic acid) 25 mg |
|
2,084.00 CHF
2,188.20 €
|
|
|
|
USP-1A03740 |
USP |
Dabigatran Etexilate Isopropyl Ester 25 mg |
|
2,084.00 CHF
2,188.20 €
|
|
|
|
USP-1A03750 |
USP |
Dabigatran Heptane-2-yl Analog (ethyl 3-(2-(((4-(N-((heptan-2-yloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate) 25 mg |
|
2,604.00 CHF
2,734.20 €
|
|
|
|
USP-1A03770 |
USP |
Bortezomib Acid Analog ((2S)-3-Phenyl-2-[(pyrazin-2-ylcarbonyl)amino]propanoic Acid) 25 mg |
|
1,389.33 CHF
1,458.80 €
|
|
|
|
USP-1A03780 |
USP |
Bortezomib Amide Analog (N-[(1S)-2-Amino-2-oxo-1-(phenylmethyl)ethyl]-2-pyrazinecarboxamide) 25 mg |
|
1,129.33 CHF
1,185.80 €
|
|
|
|
USP-1A03800 |
USP |
Lenvatinib N-Oxide (6-carbamoyl-4-(3-chloro-4-(3-cyclopropylureido)phenoxy)-7-methoxyquinoline 1-oxide) 25 mg |
|
3,037.33 CHF
3,189.20 €
|
|
|
|
USP-1A03810 |
USP |
Rifamycin O (4-O-(Carboxymethyl)-1-deoxy-1,4-dihydro-4-hydroxy-1-oxo-rifamycin gamma-Lactone) 25 mg |
|
1,216.00 CHF
1,276.80 €
|
|
|
|
USP-1A03820 |
USP |
Vilanterol Desethylene Homolog Triphenylacetate ((R)-4-(2-((6-((2,6-dichlorobenzyl)oxy)hexyl)amino)-1-hydroxyethyl)-2-(hydroxymethyl)phenol, 2,2,2-triphenylacetate) 25 mg |
|
2,604.00 CHF
2,734.20 €
|
|
|
|
USP-1A03830 |
USP |
2,4-Dichloro Vilanterol Trifenatate Isomer ((R)-4-(2-((6-(2-((2,4-dichlorobenzyl)oxy)ethoxy)hexyl)amino)-1-hydroxyethyl)-2-(hydroxymethyl)phenol, triphenylacetate) 25 mg |
|
3,037.33 CHF
3,189.20 €
|
|
|
|
USP-1A03840 |
USP |
2,5-Dichloro Vilanterol Trifenatate Isomer ((R)-4-(2-((6-(2-((2,5-dichlorobenzyl)oxy)ethoxy)hexyl)amino)-1-hydroxyethyl)-2-(hydroxymethyl)phenol, 2,2,2-triphenylacetate) 25 mg |
|
2,604.00 CHF
2,734.20 €
|
|
|
|
USP-1A03850 |
USP |
Vilanterol Trifenatate S-Enantiomer ((S)-4-(2-((6-(2-((2,6-dichlorobenzyl)oxy)ethoxy)hexyl)amino)-1-hydroxyethyl)-2-(hydroxymethyl)phenol 2,2,2-triphenylacetate) 25 mg |
|
3,385.33 CHF
3,554.60 €
|
|
|
|
USP-1A03860 |
USP |
Vilanterol Trifenatate Dioxin ((alphaR)-alpha-[[[6-[2-[(2,6- Dichlorophenyl)methoxy] ethoxy]hexyl] amino]methyl]-2,2-dimethyl-4H-1,3-benzodioxin-6-methanol, triphenylacetate) 50 mg |
|
2,257.33 CHF
2,370.20 €
|
|
|
|
USP-1A03870 |
USP |
D-Epinephrine ((S)-4-[1-Hydroxy-2-(methylamino)ethyl]pyrocatechol) 25 mg |
|
912.00 CHF
957.60 €
|
|
|
|
USP-1A03910 |
USP |
Vilanterol Diamine Triphenylacetate (4,4'-((1R,1'R)-((oxybis(hexane-6,1-diyl))bis(azanediyl))bis(1-hydroxyethane-2,1-diyl))bis(2-(hydroxymethyl)phenol), 2,2,2-triphenylacetate)) 25 mg |
|
2,864.00 CHF
3,007.20 €
|
|
|
|
USP-1A03920 |
USP |
N-Nitroso Varenicline (NNV) Solution (1 mg/mL in Methanol) (8-nitroso-7,8,9,10-tetrahydro-6H-6,10-methanoazepino[4,5-g]quinoxaline) 1 mL |
|
738.67 CHF
775.60 €
|
|
|
|
USP-1A03930 |
USP |
N-Nitrosodipropylamine (NDPA) Solution (1 mg/mL in Methanol) (N,N-dipropylnitrous amide) 1 mL |
|
712.00 CHF
747.60 €
|
|
|
|
USP-1A03940 |
USP |
N-Nitrosomethylphenidate (NMPH) Solution (1 mg/mL in Methanol) (Methyl 2-(1-nitrosopiperidin-2-yl)-2-phenylacetate) 1 mL |
|
669.33 CHF
702.80 €
|
|
|
|
USP-1A03950 |
USP |
N-Nitrosopiperidine Solution (1 mg/mL in Methanol) (1-Nitrosopiperidine) 1 mL |
|
686.67 CHF
721.00 €
|
|
|
|
USP-1A03960 |
USP |
N-Nitroso Sitagliptin Amine (NTTP) Solution (1 mg/mL in Methanol) (7-nitroso-3-(trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine) 1 mL |
|
669.33 CHF
702.80 €
|
|
|
|
USP-1A03970 |
USP |
N-Nitroso-1,2,3,6-tetrahydropyridine (NTHP) Solution (1 mg/mL in Methanol) (1-nitroso-1,2,3,6-tetrahydropyridine) 1 mL |
|
677.33 CHF
711.20 €
|
|
